Sravanthi Cheeti
Sunesis (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Fibroblast Growth Factor Research, Hedgehog Signaling Pathway Studies
Most-Cited Works
- → Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)(2012)247 cited
- → Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding(2011)117 cited
- → A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer(2012)105 cited
- → Pharmacokinetic Dose-Scheduling Study of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors(2011)89 cited
- → Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometry(2010)40 cited
- → Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study(2022)37 cited
- → A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS(2022)36 cited
- → GDC-0810 Pharmacokinetics and Transporter-Mediated Drug Interaction Evaluation with an Endogenous Biomarker in the First-in-Human, Dose Escalation Study(2019)33 cited
- → Effect of OATP1B1/1B3 Inhibitor GDC‐0810 on the Pharmacokinetics of Pravastatin and Coproporphyrin I/III in Healthy Female Subjects(2018)33 cited
- → Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer(2024)30 cited